Therefore, it would be reasonable to posit that while leptin may elicit a therapeutic response at physiologically relevant concentrations, this beneficial effect of leptin is completely abrogated in diseased states such as obesity and diabetes, characterized by hyperleptinemia. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.